The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pakola Steve since 2022.
This trader's CIK number is 1700659.
At the time of last reporting, Pakola Steve was the Chief Medical Officer of Regenxbio Inc.. (stock ticker symbol RGNX).
Also see all insider trading activities at Regenxbio Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RGNX | 0 | $0 | 12,878 | $365,220 | 12,878 | $286,535 |
| 2023 | RGNX | 0 | $0 | 3,138 | $69,560 | 0 | $0 |
| 2022 | RGNX | 0 | $0 | 1,598 | $53,932 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-05 | RGNX | Sale | 12,878 | 28.36 | 365,220 |
| 2024-03-05 | RGNX | Option Ex | 12,878 | 22.25 | 286,535 |
| 2023-01-03 | RGNX | Sale | 3,138 | 22.17 | 69,560 |
| 2022-01-03 | RGNX | Sale | 1,598 | 33.75 | 53,932 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pakola Steve (Chief Medical Officer of Regenxbio Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.